Protein Assays

The gene DSCR4 (Down syndrome critical region protein-4) is mapped to human chromosome 21q22.2.

Anti-EHBP1L1 EH domain binding protein 1-like 1, 25ul UN 168

Immunogen Protein FAM176A (Transmembrane protein 166) Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are supported by the most extensive

FAM213A (family with sequence similarity 213 member A) is a perirdeoxin-like protein, which contains a CXXC motif. Upon stimulation by M-CSF (macrophage-colony stimulating factor) and RANKL (receptor activator of nuclear factor &#954-B ligand),

Immunogen FAM21C (AAH06456, 1 a.a.

Immunogen Fibulin-1 precursor recombinant protein epitope signature tag (PrEST) Application Anti-FBLN1 antibody produced in rabbit is suitable as an antibody suspension bead array in affinity proteomic array to explore the potential of the human

Fluorescein is synthesized from m -dialkylaminophenols or resorcinols condensed with phthalic anhydrides under harsh conditions. Fab fragments bind to G proteins.

Frataxin (FXN) is a mitochondrial protein, located on human chromosome 9. It is produced in the cytoplasm and migrated to the mitochondria through a signal peptide.

General description Gemin-2 (also known as SIP1 or SMN interacting protein1) is a part of the SMN complex. The SMN complex plays a role in RNA metabolism and in splicing regulation.

Immunogen Recombinant protein fragment contain a sequence corresponding to a region within amino acids 67 and 271 of GNB1 according to AAH04186 Application Suggested starting dilutions are as follows: ICC/IF: 1:100-1:1000, IHC-P: 1:100-1:1000,

The gene GREB1 (growth regulation by estrogen in breast cancer 1) is mapped to human chromosome 2p25. Immunogen growth regulation by estrogen in breast cancer 1 recombinant protein epitope signature tag (PrEST) Application Anti-GREB1 antibody

General description GREB1, also known as gene regulated in breast cancer protein 1 is shown to be involved in the proliferation of breast cancer cells, controlled by estrogen. GREB1 has the potential to be a clinical marker for response to